South Korea's SK Bioscience to buy 60% stake in Germany's IDT Biologika for $244m

South Korea's SK Bioscience to buy 60% stake in Germany's IDT Biologika for $244m

The logo of SK Innovation is seen in front of its headquarters in Seoul, South Korea. REUTERS/Kim Hong-Ji

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter